Editorial
doi: 10.1001/jamainternmed.2015.7927.
Adverse Effects Associated With Proton Pump Inhibitors
Affiliations
- PMID: 26751904
- DOI: 10.1001/jamainternmed.2015.7927
Item in Clipboard
Editorial
Adverse Effects Associated With Proton Pump Inhibitors
JAMA Intern Med.
2016 Feb.
No abstract available
Comment on
-
Proton Pump Inhibitor Use and the Risk of Chronic Kidney Disease.JAMA Intern Med. 2016 Feb;176(2):238-46. doi: 10.1001/jamainternmed.2015.7193. JAMA Intern Med. 2016. PMID: 26752337 Free PMC article.
Similar articles
-
Proton pump inhibitors are associated with risk of chronic kidney disease, study finds.BMJ. 2016 Jan 12;352:i128. doi: 10.1136/bmj.i128. BMJ. 2016. PMID: 26759185 No abstract available.
-
PPI können die Nieren schädigen.Praxis (Bern 1994). 2016 Apr 13;105(8):471-2. doi: 10.1024/1661-8157/a002326. Praxis (Bern 1994). 2016. PMID: 27078733 German. No abstract available.
-
Is red meat consumption the confounding factor explaining the association between chronic kidney disease and proton pump inhibitors?Nephrol Ther. 2019 Jul;15(4):191-192. doi: 10.1016/j.nephro.2018.11.011. Epub 2019 May 2. Nephrol Ther. 2019. PMID: 31056405 No abstract available.
-
The association of proton pump inhibitors and chronic kidney disease: cause or confounding?Curr Opin Nephrol Hypertens. 2018 May;27(3):182-187. doi: 10.1097/MNH.0000000000000406. Curr Opin Nephrol Hypertens. 2018. PMID: 29432214 Review.
-
Associations of Proton-Pump Inhibitors and H2 Receptor Antagonists with Chronic Kidney Disease: A Meta-Analysis.Dig Dis Sci. 2017 Oct;62(10):2821-2827. doi: 10.1007/s10620-017-4725-5. Epub 2017 Aug 23. Dig Dis Sci. 2017. PMID: 28836158 Review.
Cited by
-
Physicians' perceptions and awareness of adverse effects of proton pump inhibitors and impact on prescribing patterns.Front Pharmacol. 2024 Jun 26;15:1383698. doi: 10.3389/fphar.2024.1383698. eCollection 2024. Front Pharmacol. 2024. PMID: 38989150 Free PMC article.
-
Efficacy and safety of Piwei Peiyuan Prescription in the treatment of chronic atrophic gastritis: A multicenter, double-blind, double-simulated, randomized, controlled clinical trial.Medicine (Baltimore). 2024 May 10;103(19):e37981. doi: 10.1097/MD.0000000000037981. Medicine (Baltimore). 2024. PMID: 38728508 Free PMC article. Clinical Trial.
-
Patients' Knowledge and Pharmacists' Practice Regarding the Long-Term Side Effects of Proton Pump Inhibitors; a Cross-sectional Study.Arch Acad Emerg Med. 2024 Mar 7;12(1):e35. doi: 10.22037/aaem.v12i1.2305. eCollection 2024. Arch Acad Emerg Med. 2024. PMID: 38721447 Free PMC article.
-
Non-indicated initiation of proton pump inhibitor and risk of adverse outcomes in patients with underlying chronic kidney disease: a nationwide, retrospective, cohort study.BMJ Open. 2024 Jan 29;14(1):e078032. doi: 10.1136/bmjopen-2023-078032. BMJ Open. 2024. PMID: 38286693 Free PMC article.
-
Clinical efficacy of Yukgunja-tang combined with a proton pump inhibitor for refractory gastroesophageal reflux disease: study protocol for randomized, double-blind, double-dummy clinical trial.BMC Complement Med Ther. 2023 Dec 7;23(1):444. doi: 10.1186/s12906-023-04283-3. BMC Complement Med Ther. 2023. PMID: 38062418 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
